This notice is to inform you that the Division of Consumer Affairs (“Division”) has issued an Administrative Order (“AO”) modifying AO 2021-11, which governed the provision of health care services in office settings in light of the COVID-19 pandemic. The AO, DCA-AO-2022-01, now requires health care professionals who provide care in office settings to monitor and adhere to any guidance issued by the Centers for Disease Control and Prevention (“CDC”), the New Jersey Department of Health (“NJDOH”), the Occupational Safety and Health Administration (“OSHA”), and local health departments. This change will help ensure that the provision of health care in office settings is consistent with prevailing health and safety standards, as they evolve over time.

What does this mean?: In speaking with several of our health care partner Clients, it is our understanding that outpatient facilities and other medical office spaces associated with health care networks, now also have to follow “CDC/DOH Hospital protocols” in terms of facility EH&S. This means that those hospital facilities that test for Legionella, medical gasses, laboratory chemicals, etc., now have to also arrange for these test methods in off-campus facilities. We at Omega look forward to providing compliance solutions for this new requirement.

There is also another Legionella regulation pending for public buildings in NJ.

(NJ Lead-Safe Certification N.J.A.C. 5:28A effective 7/22/2022) – Omega has a team of certified Lead Inspectors/Risk Assessors available to perform “Lead-Safe” visual and XRF inspections in pre-1978 rental housing.)

(NYC 0.5 XRF Lead Inspections for HPD Compliance)

Omega has a team of Lead Inspectors/Risk Assessors to perform updated residential XRF inspections down to the updated 0.5 mg/cm2 Lead XRF and lower Lead Surface Dust criteria.